David Stanton
Stock Analyst at Jefferies
(4.20)
# 1,316
Out of 5,032 analysts
246
Total ratings
45.5%
Success rate
11.6%
Average return
Main Sectors:
Stocks Rated by David Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Reiterated: Hold | $146.50 → $161.50 | $180.91 | -10.73% | 26 | Oct 6, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $30.00 → $32.00 | $16.07 | +99.13% | 26 | Sep 30, 2026 | |
| ASX: HLS Healius Limited | Reiterated: Hold | $0.41 → $0.44 | $0.40 | +10.00% | 19 | Sep 25, 2026 | |
| ASX: IMM Immutep Limited | Upgraded: Buy | $0.04 → $0.08 | $0.03 | +166.67% | 9 | Sep 15, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Buy | $0.83 → $0.80 | $0.75 | +6.67% | 12 | Sep 1, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Reiterated: Buy | $40.80 → $39.30 | $8.18 | +380.44% | 12 | Aug 30, 2026 | |
| ASX: MSB Mesoblast Limited | Reiterated: Buy | $3.00 → $2.90 | $2.05 | +41.46% | 17 | Aug 30, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $39.80 → $48.50 | $54.97 | -11.77% | 13 | Aug 30, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Reiterated: Buy | $3.30 → $3.20 | $2.65 | +20.98% | 18 | Aug 30, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.50 → $3.30 | $2.13 | +54.93% | 11 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29.40 → $28.90 | $20.04 | +44.21% | 19 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $128.40 → $144.75 | $130.96 | +10.53% | 20 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188.25 → $196.95 | $161.43 | +22.00% | 6 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23.00 → $21.00 | $18.84 | +11.46% | 22 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.00 → $5.60 | $2.02 | +177.23% | 12 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.61 | n/a | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.87 | n/a | 3 | Apr 8, 2021 |
CSL Limited
Oct 6, 2026
Reiterated: Hold
Price Target: $146.50 → $161.50
Current: $180.91
Upside: -10.73%
Telix Pharmaceuticals Limited
Sep 30, 2026
Reiterated: Buy
Price Target: $30.00 → $32.00
Current: $16.07
Upside: +99.13%
Healius Limited
Sep 25, 2026
Reiterated: Hold
Price Target: $0.41 → $0.44
Current: $0.40
Upside: +10.00%
Immutep Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $0.04 → $0.08
Current: $0.03
Upside: +166.67%
Monash IVF Group Limited
Sep 1, 2026
Reiterated: Buy
Price Target: $0.83 → $0.80
Current: $0.75
Upside: +6.67%
Clinuvel Pharmaceuticals Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $40.80 → $39.30
Current: $8.18
Upside: +380.44%
Mesoblast Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $3.00 → $2.90
Current: $2.05
Upside: +41.46%
Ramsay Health Care Limited
Aug 30, 2026
Reiterated: Hold
Price Target: $39.80 → $48.50
Current: $54.97
Upside: -11.77%
Sigma Healthcare Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $3.30 → $3.20
Current: $2.65
Upside: +20.98%
Integral Diagnostics Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $3.50 → $3.30
Current: $2.13
Upside: +54.93%
Aug 27, 2026
Reiterated: Buy
Price Target: $29.40 → $28.90
Current: $20.04
Upside: +44.21%
Aug 20, 2026
Reiterated: Hold
Price Target: $128.40 → $144.75
Current: $130.96
Upside: +10.53%
Aug 20, 2026
Reiterated: Hold
Price Target: $188.25 → $196.95
Current: $161.43
Upside: +22.00%
Aug 20, 2026
Reiterated: Hold
Price Target: $23.00 → $21.00
Current: $18.84
Upside: +11.46%
Jul 28, 2026
Reiterated: Buy
Price Target: $5.00 → $5.60
Current: $2.02
Upside: +177.23%
Dec 6, 2022
Downgraded: Hold
Price Target: n/a
Current: $13.61
Upside: n/a
Apr 8, 2021
Downgraded: Hold
Price Target: n/a
Current: $12.87
Upside: n/a